> Pharma just wants another mass marketable drugs. Maybe. But I'm not sure how much money you could make out of ketamine, considering that it's old enough that

> Pharma just wants another mass marketable drugs. Maybe. But I'm not sure how much money you could make out of ketamine, considering that it's old enough that it's AFAIK not under any patents, and it's not a daily drug so even volume and mass marketing might not make it that lucrative. If my memory serves, the related esketamine might actually be under some kind of a patent, but if you wanted to make money out of that, you'd probably want to show the efficacy of that particular enantiomer, including over plain old ketamine. I share the concern that ketamine might be yet another thing to try and treat symptoms with, and could make people even more dependent on medication-based approaches. However, doctors would probably just like to have further means of alleviating or treating conditions that they currently don't know how to treat, and although you could still call the medical field out for focusing too much on medication, I'm not sure the motivation in this case is "more money".